Acupath Laboratories Announces Expansion of COVID-19 Test Offerings With Introduction of Low-Cost Saliva PCR Assay

April 14, 2021by Acupath

“Acupath Laboratories introduce Low-Cost Saliva PCR Assay. (Credit: PIRO4D from Pixabay.)

Acupath Laboratories, Inc., a leading provider of sub-specialized anatomic and molecular pathology services, today announced the availability of COVID-19 saliva PCR testing. Expanding COVID-19 testing options to include saliva provides organizations with an easier and faster alternative to the nasal swab PCR, which is often perceived as uncomfortable and invasive, particularly when conducted on a regular basis.”

Read Full Article

ACUPATH LABORATORIES ANNOUNCES EXPANSION OF COVID-19 TEST OFFERINGS WITH INTRODUCTION OF LOW-COST SALIVA PCR ASSAY

Benasource Selects Acupath Laboratories to Bring COVID-19 Saliva PCR Assay to Independent Pharmacies Across the Country

Sample Collection Instructions

Fact Sheet For Patients

Fact Sheet For Healthcare Providers

This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

*electronic orders for direct bill customers only, other terms and conditions may apply.

**insurance availability and copayment/coinsurance requirements are based on current government guidance and is subject to revision if/when plan/payor requirements evolve

The COVID-19 Pandemic is a rapidly evolving situation and guidance is updated frequently. Check your destination’s COVID-19 situation BEFORE traveling. Country, State, local, and territorial governments may have specific travel restrictions or requirements in place. It is ultimately the traveling individuals responsibility to confirm their destinations policy.

1 (516) 775-8103

[email protected]

28 South Terminal Drive, Plainview, NY 11803